Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast Cancer

3 Jan 2014

Abstract excerpt

TNBC is an aggressive breast cancer subtype that does not express hormone receptors (estrogen and progesterone receptors, ER and PR) or amplified human epidermal growth factor receptor type 2 (HER2), and there currently exist no targeted therapies effective against it. Consequently, finding new molecular targets in triple negative breast cancer (TNBC) is critical to improving patient outcomes. Previously, we have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer-related Molecular Pathways
Share to Cancer, Stress, Anesthesia, and Immune Response

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24404125
DOI: 10.1371/journal.pone.0081126

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabotropic Glutamate Receptor-1 Contributes to Progression in Triple Negative Breast CancerPMID 24404125Read ↗

Metabotropic glutamate receptor-1: a potential therapeutic target for the treatment of breast cancer.Semantic proximity Read ↗

Metabotropic Glutamate Receptor-1 as a Novel Target for the Antiangiogenic Treatment of Breast CancerSemantic proximity Read ↗

Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.Semantic proximity Read ↗

Somatic mutations in GRM1 in cancer alter metabotropic glutamate receptor 1 intracellular localization and signaling.Semantic proximity Read ↗

Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.Semantic proximity Read ↗

Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.Semantic proximity Read ↗

RNAi Screening in Primary Human Breast Biopsies Identifies Mitochondrial Glutamate Flux as A Metabolic Vulnerability in Locally Advanced Breast CancerSemantic proximity Read ↗

Reduced glutamate decarboxylase 1 underlies morphine-promoted lung metastasis of triple-negative breast cancer in miceSemantic proximity Read ↗

GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)Semantic proximity Read ↗

Glutamate receptors: emerging players in melanomagenesis.Semantic proximity Read ↗

Glutamate Ionotropic Receptor Kainate Type Subunit 3 (GRIK3) promotes epithelial‐mesenchymal transition in breast cancer cells by regulating SPDEF/CDH1 signalingSemantic proximity Read ↗

Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.